Piramal Enterprises announced acquisition of five brands from Organon India and MSD BV for INR 0.92bn to beef up its offerings in the OTC healthcare segment.
-- Ø Sanofi Pasteur received Food and Drug Administration of Philippines approval to market its Dengvaxia vaccine to be licensed for the prevention of dengue in Asia.
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.
No comments:
Post a Comment